Expression of P-glycoprotein and CYP3A4 along the porcine oral-gastrointestinal tract: implications on oral mucosal drug delivery

References

• Ueda K, Cornwell MM, Gottesman MM, et al. The mdr1 gene, responsible for multidrug-resistance, codes for P-glycoprotein. Biochem Biophys Res Commun 1986;141:956–62
   PubMed Web of Science ®Google Scholar
• Willingham MC, Cornwell MM, Cardarelli CO, et al. Single cell analysis of daunomycin uptake and efflux in multidrug-resistant and -sensitive KB cells: effects of verapamil and other drugs. Cancer Res 1986;46:5941–6
   PubMed Web of Science ®Google Scholar
• Thiebaut F, Tsuruo T, Hamada H, et al. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci U S A 1987;84:7735–8
   PubMed Web of Science ®Google Scholar
• Greiner B, Eichelbaum M, Fritz P, et al. The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin. J Clin Invest 1999;104:147–53
   PubMed Web of Science ®Google Scholar
• Gramatte T, Oertel R, Terhaag B, Kirch W. Direct demonstration of small intestinal secretion and site-dependent absorption of the beta-blocker talinolol in humans. Clin Pharmacol Ther 1996;59:541–9
   PubMed Web of Science ®Google Scholar
• Chiou WL, Chung SM, Wu TC, Ma C. A comprehensive account on the role of efflux transporters in the gastrointestinal absorption of 13 commonly used substrate drugs in humans. Int J Clin Pharmacol Ther 2001;39:93–101
   PubMed Web of Science ®Google Scholar
• Igel S, Drescher S, Murdter T, et al. Increased absorption of digoxin from the human jejunum due to inhibition of intestinal transporter-mediated efflux. Clin Pharmacokinet 2007;46:777–85
   PubMed Web of Science ®Google Scholar
• Woo JS, Lee CH, Shim CK, Hwang SJ. Enhanced oral bioavailability of paclitaxel by coadministration of the P-glycoprotein inhibitor KR30031. Pharm Res 2003;20:24–30
   PubMed Web of Science ®Google Scholar
• Schwarz UI, Gramatte T, Krappweis J, et al. P-glycoprotein inhibitor erythromycin increases oral bioavailability of talinolol in humans. Int J Clin Pharmacol Ther 2000;38:161–7
   PubMed Web of Science ®Google Scholar
• Guengerich FP, Mason PS. Immunological comparison of hepatic and extrahepatic cytochromes P-450. Mol Pharmacol 1979;15:154–64
   PubMed Web of Science ®Google Scholar
• Zhang QY, Dunbar D, Ostrowska A, et al. Characterization of human small intestinal cytochromes P-450. Drug Metab Dispos 1999;27:804–9
   PubMed Web of Science ®Google Scholar
• Kato M. Intestinal first-pass metabolism of CYP3A4 substrates. Drug Metab Pharmacokinet 2008;23:87–94
   PubMed Web of Science ®Google Scholar
• Wacher VJ, Wu CY, Benet LZ. Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: implications for drug delivery and activity in cancer chemotherapy. Mol Carcinog 1995;13:129–34
   PubMed Web of Science ®Google Scholar
• Kivisto KT, Niemi M, Fromm MF. Functional interaction of intestinal CYP3A4 and P-glycoprotein. Fundam Clin Pharmacol 2004;18:621–6
   PubMed Web of Science ®Google Scholar
• Wacher VJ, Salphati L, Benet LZ. Active secretion and enterocytic drug metabolism barriers to drug absorption. Adv Drug Deliv Rev 2001;46:89–102
   PubMed Web of Science ®Google Scholar
• Mouly S, Paine MF. P-glycoprotein increases from proximal to distal regions of human small intestine. Pharm Res 2003;20:1595–9
   PubMed Web of Science ®Google Scholar
• Zhang H, Zhang J, Streisand JB. Oral mucosal drug delivery: clinical pharmacokinetics and therapeutic applications. Clin Pharmacokinet 2002;41:661–80
   PubMed Web of Science ®Google Scholar
• Vondracek M, Xi Z, Larsson P, et al. Cytochrome P450 expression and related metabolism in human buccal mucosa. Carcinogenesis 2001;22:481–8
   PubMed Web of Science ®Google Scholar
• Kragelund C, Hansen C, Torpet LA, et al. Expression of two drug-metabolizing cytochrome P450-enzymes in human salivary glands. Oral Dis 2008;14:533–40
   PubMed Web of Science ®Google Scholar
• Vondracek M, Weaver DA, Sarang Z, et al. Transcript profiling of enzymes involved in detoxification of xenobiotics and reactive oxygen in human normal and simian virus 40 T antigen-immortalized oral keratinocytes. Int J Cancer 2002;99:776–82
   PubMed Web of Science ®Google Scholar
• Lesch CA, Squier CA, Cruchley A, et al. The permeability of human oral mucosa and skin to water. J Dent Res 1989;68:1345–9
   PubMed Web of Science ®Google Scholar
• De Caro V, Giandalia G, Siragusa MG, et al. Evaluation of galantamine transbuccal absorption by reconstituted human oral epithelium and porcine tissue as buccal mucosa models: part I. Eur J Pharm Biopharm 2008;70:869–73
   PubMed Web of Science ®Google Scholar
• Kulkarni U, Mahalingam R, Pather SI, et al. Porcine buccal mucosa as an in vitro model: relative contribution of epithelium and connective tissue as permeability barriers. J Pharm Sci 2009;98:471–83
   PubMed Web of Science ®Google Scholar
• Chetty DJ, Chen LL, Chien YW. Characterization of captopril sublingual permeation: determination of preferred routes and mechanisms. J Pharm Sci 2001;90:1868–77
   PubMed Web of Science ®Google Scholar
• Rodrigo MC, Martin DS, Redetzke RA, Eyster KM. A method for the extraction of high-quality RNA and protein from single small samples of arteries and veins preserved in RNAlater. J Pharmacol Toxicol Methods 2002;47:87–92
   PubMed Web of Science ®Google Scholar
• Luu TC, Bhattacharya P, Chan WK. Cyclophilin-40 has a cellular role in the aryl hydrocarbon receptor signaling. FEBS Lett 2008;582:3167–73
   PubMed Web of Science ®Google Scholar
• Berggren S, Gall C, Wollnitz N, et al. Gene and protein expression of P-glycoprotein, MRP1, MRP2, and CYP3A4 in the small and large human intestine. Mol Pharm 2007;4:252–7
   PubMed Web of Science ®Google Scholar
• Taipalensuu J, Tavelin S, Lazorova L, et al. Exploring the quantitative relationship between the level of MDR1 transcript, protein and function using digoxin as a marker of MDR1-dependent drug efflux activity. Eur J Pharm Sci 2004;21:69–75
   PubMed Web of Science ®Google Scholar
• Woodahl EL, Ho RJ. The role of MDR1 genetic polymorphisms in interindividual variability in P-glycoprotein expression and function. Curr Drug Metab 2004;5:11–19
   PubMed Web of Science ®Google Scholar
• Pal D, Mitra AK. MDR- and CYP3A4-mediated drug–drug interactions. J Neuroimmune Pharmacol 2006;1:323–39
   PubMed Web of Science ®Google Scholar
• Zhou SF, Lai X. An update on clinical drug interactions with the herbal antidepressant St. John's wort. Curr Drug Metab 2008;9:394–409
   PubMed Web of Science ®Google Scholar
• Thummel KE, O'Shea D, Paine MF, et al. Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolism. Clin Pharmacol Ther 1996;59:491–502
   PubMed Web of Science ®Google Scholar
• Thorn M, Finnstrom N, Lundgren S, et al. Cytochromes P450 and MDR1 mRNA expression along the human gastrointestinal tract. Br J Clin Pharmacol 2005;60:54–60
   PubMed Web of Science ®Google Scholar
• von Richter O, Burk O, Fromm MF, et al. Cytochrome P450 3A4 and P-glycoprotein expression in human small intestinal enterocytes and hepatocytes: a comparative analysis in paired tissue specimens. Clin Pharmacol Ther 2004;75:172–83
   PubMed Web of Science ®Google Scholar